176 related articles for article (PubMed ID: 26176330)
1. The small GTPase ADP-Ribosylation Factor 1 mediates the sensitivity of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors.
Haines E; Schlienger S; Claing A
Cancer Biol Ther; 2015; 16(10):1535-47. PubMed ID: 26176330
[TBL] [Abstract][Full Text] [Related]
2. The adaptor proteins p66Shc and Grb2 regulate the activation of the GTPases ARF1 and ARF6 in invasive breast cancer cells.
Haines E; Saucier C; Claing A
J Biol Chem; 2014 Feb; 289(9):5687-703. PubMed ID: 24407288
[TBL] [Abstract][Full Text] [Related]
3. ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions.
Schlienger S; Ramirez RA; Claing A
Cell Signal; 2015 Mar; 27(3):403-15. PubMed ID: 25530216
[TBL] [Abstract][Full Text] [Related]
4. ARF1 controls Rac1 signaling to regulate migration of MDA-MB-231 invasive breast cancer cells.
Lewis-Saravalli S; Campbell S; Claing A
Cell Signal; 2013 Sep; 25(9):1813-9. PubMed ID: 23707487
[TBL] [Abstract][Full Text] [Related]
5. ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer.
Schlienger S; Campbell S; Pasquin S; Gaboury L; Claing A
Oncotarget; 2016 Mar; 7(13):15811-27. PubMed ID: 26908458
[TBL] [Abstract][Full Text] [Related]
6. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
7. ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells.
Boulay PL; Cotton M; Melançon P; Claing A
J Biol Chem; 2008 Dec; 283(52):36425-34. PubMed ID: 18990689
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis.
He L; Gao L; Shay C; Lang L; Lv F; Teng Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):84. PubMed ID: 30777099
[TBL] [Abstract][Full Text] [Related]
9. An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).
Ferrer-Soler L; Vazquez-Martin A; Brunet J; Menendez JA; De Llorens R; Colomer R
Int J Mol Med; 2007 Jul; 20(1):3-10. PubMed ID: 17549382
[TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors.
Choi YJ; Rho JK; Jeon BS; Choi SJ; Park SC; Lee SS; Kim HR; Kim CH; Lee JC
Cancer Chemother Pharmacol; 2010 Jul; 66(2):381-8. PubMed ID: 19921194
[TBL] [Abstract][Full Text] [Related]
11. ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein.
Boulay PL; Schlienger S; Lewis-Saravalli S; Vitale N; Ferbeyre G; Claing A
Oncogene; 2011 Sep; 30(36):3846-61. PubMed ID: 21478909
[TBL] [Abstract][Full Text] [Related]
12. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
Qin B; Ariyama H; Baba E; Tanaka R; Kusaba H; Harada M; Nakano S
Cancer Chemother Pharmacol; 2006 Nov; 58(5):577-84. PubMed ID: 16532343
[TBL] [Abstract][Full Text] [Related]
13. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
[TBL] [Abstract][Full Text] [Related]
14. The mechanism and function of mitogen-activated protein kinase activation by ARF1.
Zhou F; Dong C; Davis JE; Wu WH; Surrao K; Wu G
Cell Signal; 2015 Oct; 27(10):2035-2044. PubMed ID: 26169956
[TBL] [Abstract][Full Text] [Related]
15. Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma.
López-Ginés C; Navarro L; Muñoz-Hidalgo L; Buso E; Morales JM; Gil-Benso R; Gregori-Romero M; Megías J; Roldán P; Segura-Sabater R; Almerich-Silla JM; Monleón D; Cerdá-Nicolás M
Cell Oncol (Dordr); 2017 Aug; 40(4):389-399. PubMed ID: 28631186
[TBL] [Abstract][Full Text] [Related]
16. Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1.
Xie X; Tang SC; Cai Y; Pi W; Deng L; Wu G; Chavanieu A; Teng Y
Oncotarget; 2016 Sep; 7(36):58111-58120. PubMed ID: 27517156
[TBL] [Abstract][Full Text] [Related]
17. Regulation of α(2B)-adrenergic receptor-mediated extracellular signal-regulated kinase 1/2 (ERK1/2) activation by ADP-ribosylation factor 1.
Dong C; Li C; Wu G
J Biol Chem; 2011 Dec; 286(50):43361-9. PubMed ID: 22025613
[TBL] [Abstract][Full Text] [Related]
18. EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells.
Grøvdal LM; Kim J; Holst MR; Knudsen SL; Grandal MV; van Deurs B
Cell Signal; 2012 Jan; 24(1):296-301. PubMed ID: 21951604
[TBL] [Abstract][Full Text] [Related]
19. The Host GTPase Arf1 and Its Effectors AP1 and PICK1 Stimulate Actin Polymerization and Exocytosis To Promote Entry of Listeria monocytogenes.
Saila S; Gyanwali GC; Hussain M; Gianfelice A; Ireton K
Infect Immun; 2020 Jan; 88(2):. PubMed ID: 31740529
[No Abstract] [Full Text] [Related]
20. Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition.
Agelaki S; Spiliotaki M; Markomanolaki H; Kallergi G; Mavroudis D; Georgoulias V; Stournaras C
Cancer Biol Ther; 2009 Aug; 8(15):1470-7. PubMed ID: 19483462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
